Tag Archives: Biotech Stock Sales

Cargo Therapeutics CEO sells over $250k in company stock, a move that has sparked curiosity and raised eyebrows within the biotech industry. This significant transaction, involving a substantial sum of the CEO’s personal holdings, begs the question: what does this tell us about the company’s trajectory and the CEO’s confidence …

Read More »